News

Metastatic castration-resistant prostate cancer (mCRPC) treatment can involves chemotherapy, radiation, and more. Find the ...
Metastatic castration-resistant prostate cancer causes urinary symptoms, fatigue, pain, and more. This article covers the ...
Artificial intelligence can help urologists and oncologists make treatment recommendations that are objective and evidence-based.
The hope is the therapy can effectively target cancerous cells at relatively small doses while minimizing side effects.
Graham Dean is convinced he would not be here today to enjoy his retirement if he hadn't received an invitation through the post one day for a prostate cancer screening check.
Graham Dean is convinced he would not be here today to enjoy his retirement if he hadn't received an invitation through the ...
A team of University of Kentucky Markey Cancer Center researchers has found the mechanism that grants prostate cancer ...
Brachytherapy Device Market Limited expertise in certain regions restricts the widespread adoption of brachytherapy US, NY, UNITED STAT ...
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have validated a test that can accurately predict which ...
"It’s crucial that patients and their families know about this new option," said Dr. William Russell, an oncology radiologist ...
Daniel Spratt and Alicia Morgans discuss clinical outcomes of patients with Gleason score 9-10 prostate cancer after definitive treatment. Long-term Survival in Men with Gleason Score 9-10 Treated ...
BPH is more common as men age. According to the Prostate Cancer Foundation, about 20% of men in their 50s have an enlarged prostate, 60% of men in their 60s, and 70% of men by age 70. Let’s ...